First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia

Clinical trial NCT00322452 · COMPLETED

Trial details

NCT number: NCT00322452
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2006-03-01
Primary completion: 2008-04-01
Enrollment: 1329

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.